Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
about
Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the SpotClinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondCombined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.Control of B lymphocyte development and functions by the mTOR signaling pathways.mTOR Signaling in Growth, Metabolism, and Disease.Emerging role of mTOR in the response to cancer therapeutics.Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinomaA study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia.Sestrin1, a tumor suppressor that can be rescued.Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanomaThe genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
P2860
Q26748629-98D4A66B-DD5D-4478-B226-BA7EE315D814Q27027493-20F73EF3-BAAC-424F-BBD6-ABCBA4376F9EQ37558207-8972E947-0C9B-46FF-B5E8-36D76C469E90Q37609908-18A0E76D-9A89-4A84-8C74-5D5AC3107E47Q38616932-A474FEB8-C6DE-4FBB-843F-6887424714C6Q38669131-5366F463-F381-4A39-BA5D-170BC5C32D80Q38674507-303EE458-B6B9-4AAF-B791-61BC4F767F21Q38747508-FF007002-3830-4C48-AEAC-D1FEBBA08986Q38964435-18F00E74-A8F0-4DDD-A3E7-A1ECA8BB9094Q39221094-480669E2-AF99-400A-BA2A-3D785F3CFE01Q39706167-EA5E23C9-3877-4FA1-94D3-B5B49D3D7549Q40953476-4FB20C5F-B0F8-4355-9327-C2EFC03A58E2Q40989877-17A76D46-EBCC-4B82-BF4B-9E76D2BB8133Q41288484-0828588A-381E-4561-8681-A10C4BB0306AQ41438291-F42D1E87-DC63-48D6-B6F2-CB1720FBB337Q41875534-D5FAD233-E89C-4828-ABF4-C780E1A4DA0AQ47169310-E0653B1F-D5E9-4A8B-A892-67EC65F7A795Q48592284-98273749-8EBD-4AB6-B138-0BC7AA1E8581Q50056038-C7F5F150-FBC0-4888-85D7-CD7FD3F26684Q55261273-2ED11CAF-AA57-4F9C-AFF8-A77EC58E927CQ58705231-C0EDF36B-4BB2-4651-9F1F-EA99881EA0C0Q58756343-86BD74E8-49D3-43E2-A4FB-E73700B55A34
P2860
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
@en
type
label
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
@en
prefLabel
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
@en
P2093
Ahad Fahad Al Seraihi
Andrew Clear
Andrew Jack
Christopher Mansbridge
David M Sabatini
Hilmar Quentmeier
Janet Matthews
John G Gribben
José Afonso Guerra-Assunção
Jude Fitzgibbon
P2860
P2888
P304
P356
10.1038/NG.3473
P407
P50
P577
2015-12-21T00:00:00Z
P6179
1044300714